论文部分内容阅读
对103例高血脂、脑动脉硬化病人,采用自身对照和历史对照的方法,服用我们研制的提高高密度脂蛋白(HDL-C)的脑脉通胶囊。服用该药1个月后血清HDL-C浓度极显著的增高(P<0.001),甘油三酯极明显下降(P<0.001),HDL-C及HDL_2-C/HDL_3-C比值明显增高(P<0.005)。同时发现该制剂有改善血液粘稠度的作用,历史对照脑脉通成分之一有抑制血小板凝集作用,抑制作用可持续12～24h以上,这对预防缺血性心、脑血管病有重要的临床价值。
103 cases of hyperlipidemia, cerebral arteriosclerosis patients, using their own control and historical control methods, we have to improve the high-density lipoprotein (HDL-C) of Naomaitong capsules. Serum HDL-C concentration significantly increased (P <0.001), triglyceride decreased significantly (P <0.001), and HDL-C and HDL 2-C / HDL 3-C ratio increased significantly <0.005). Also found that the preparation has the effect of improving blood viscosity, one of the components of the history of control brain through-line inhibition of platelet aggregation, the inhibitory effect of sustainable 12 ~ 24h above, which is important for the prevention of ischemic heart disease, cerebrovascular disease Clinical Value.